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1. Introduction 
The third component of human complement (C3) 
is composed of two polypeptide chains, (Y (110 k 
daltons) and /3 (75 k daltons) [ I-31. When C3 is 
activated, a polypeptide (C3a) of 9 k daltons is removed 
from the N-terminal part of the a: chain [4] and a 
labile binding site on the remaining molecule (C3b) 
appears [5] and can react with cell membranes [6,9] 
and with a wide variety of materials such as: zymosan 
[9], oil droplets coated with Escherichia coli lipopoly- 
saccharide [lo] and Sepharose [ 111. Furthermore, 
this binding is extremely stable. This interaction might 
involve hydrophobic interactions [I ?];an ester linkage 
is involved between the labile binding site of C3b and 
receptive surfaces [ 131. The labile binding site was 
localized in a segment containing the C3d antigenicity. 
Here, we investigated the hydrophobic properties 
of human C3 and we demonstrated that C3d was a 
true amphiphilic protein, easily prepared from aged 
sera by hydrophobic affinity chromatography. 
2. Materials and methods 
Charge shift electrophoresis experiments were 
done as in [ 141. Immune-electrophoresis and immuno- 
diffusion were carried out on 1.3% agar in 0.05 M 
barbital buffer (pH 8.3) by using anti-whole human 
serum, anti-C3d (Organon Teknika) and anti-C3c 
immunesera (prepared in our laboratory). 
C3 and C3c were purified as m [ 151. Protein con- 
centrations were determined by radial immunodiffu- 
sion (Partigen plate anti-C3c, Behring Werke AC) and 
by a dye-binding assay using Coomassie brilliant blue 
G-750 (BioRad Labs. Richmond, CA). Sodium dodecyl 
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sulphate-polyacrylamide gel electrophoresis (SDS- 
PAGE) was done following [ 161. Sera from healthy 
blood donors were incubated for 8 days at 37°C with 
0.1% NaN, then, precipitated by 0.5%’ (w/v) 
Rivanol@. The precipitate was redissolved in a 0.5 M 
NaCl solution and intensively dialyzed against 10 mM 
sodium acetate buffer (pH 5.3) [17]. The pseudoglo- 
bulin fraction was dialyzed against 0.8 M ammonium 
sulphate, 0.15 M NaCl, 0.01 M sodium phosphate 
buffer (pH 7.1) then, loaded on the top of a phenyl- 
Sepharose (Pharmacia Fine Chemicals) column 
chromatography. Elution was developed by decreasing 
the ionic strength with 5O%m(v/v) ethylene glycol (EC) 
solution in distilled water. Gel filtration of C3d rich 
fractions were performed on AcA 44 (IBF) equili- 
brated with 10% (v/v) EC, 0.1 M Tris, HCl buffer 
(PH 8). 
3. Results and discussion 
As illustrated in fig.1, incubation with Triton X-100 
did not change the electrophoretic mobilities of C3 
and C3c. C3 presented a cathodic line (fig.l(l,Z)) and 
C3c. which did not migrate on agar immuno-electro- 
phoresis. exhibited its characteristic precipitin line 
under the well (fig.l(5)). On the contrary, adding 
sodium deoxycholate to the Triton-protein mixtures 
[ 141 induced large modifications of electrophoretic 
mobilities for C3 and C3d (fig.1(3,4,7,8)), but the 
mobility of C3c was unchanged (fig.l(6)). These 
results showed that C3 had hydrophobic sites that 
bound the non-ionic detergent Triton X-100. The 
analysis of C3 fragments (C~C, C3d) clearly indicated 
that those hydrophobic sites were located on the C3d 
part of the molecule. These findings are consistent 
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with [ 181 where the binding of C3b to Sepharose was 
enhanced by the presence of non-ionic detergents, 
suggesting the presence of hydrophobic sites near the 
labile binding sites of C3b. 
The hydrophobic properties of C3d were used in 
the present study to devise an improved method for 
its purification from aged sera by hydrophobic affinity 
chromatography. 
Serum was incubated for 8 days at 37°C with 0.1% 
(w/v) NaNa. Under these conditions, C3 was com- 
pletely converted into C3c and C3d fragments. 
The pseudoglobulins (see section 2) were frac- 
tionated on a phenyl-LSepharose column chromatog- 
raphy. The ionic strength was increased with 
ammonium sulphate (0.8 M) to ensure a good fixation 
of proteins bearing hydrophobic sites. Elution was 
carried out both by decreasing the ionic strength and 
increasing the concentration of EC (fig.2). Immuno- 
diffusion analysis showed that C3d eluted in fraction 
IV and V. A protein of 25 k daltons was detected by 
SDS-PAGE in fraction V only. Gel filtration of 
fraction V permitted us to purify this protein (fig.3) 
and to identify it as C3d by immunochemical criteria. 
In SDS-PAGE, its mobility was not affected by the 
presence of mercaptoethanol (fig.3). These findings 
confirmed that C3d consisted of a single polypeptide 
chain of 25 k daltons, as preliminary in [ 191. C3d 
was isolated [2] by gel filtration of a trypsin digest 
of C3 and C3d was found made of two polypeptide 
chains. The chosen experimental procedure to purify 
C3d could account for these discrepancies. In [ 151, 
we showed that trypsin produced a high number of 
small polypeptides coming from C3c and from the 
polypeptide that joined C3d and C3c in native C3 
and therefore, could contaminate C3d preparations. 
The preparation described herein is reproducible 
and ensures a good yield (-25%). For example, we 
purified 3 mg C3d from 130 ml serum that contained 
0.68 mg native C3/ml. 
C3d is an important catabolic fragment of C3 and 
Fig.1. Immuno-electrophoresis of C3 and of its fragments 
(C3c and C3d) in the presence of Triton X-100 and sodium 
deoxycholate (DOC): (l-6) anti-C3c in the trough; (7-9) 
anti-C3d in the trough;(l,2) purified C3, Triton X-100 alone; 
(3,4) purified C3, Triton X-100 + DOC; (5) purified C3c, 
Triton X-100 alone; (6) purified C3c, Triton X-100 + DOC; 
(7,8) pseudoglobulins, Triton X-100 + DOC; (9) pseudo- 
globulins, Triton X-100 alone. 
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Fig.2. Phenyl-Sepharose affinity chromatography of the pseudoglobulin fraction. Elution was carried out both by decreasing the 
ionic strength (- - -) and increasing EC concentration (-- --). Fractions were pooled as indicated by the solid bars. 
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Fig.3. SDS-polyacrylamide gel electrophoresis. (A) Fractions from the phenyl-Sepharose affinity chromatography were analyzed 
in 5X, polyacrylamide gels containing 0.1% SDS. (a) fraction I;(b) fraction II; (c) fraction III; (d) fraction IV;(e) fraction V. (B) 
SDS-PAGE of purified C3d in 7.5% polyacrylamide gels. (a) C3d recovered from the gel filtration on AcA 44 without mercapto- 
ethanol;(b) with mercaptoethanol; (c-e) protein markers (ovalbumin 43 k daltons, trypsin 25 k daltons and albumin 68 k daltons). 
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the knowledge of its serum level in patients affected 
with renal diseases is very important. The use of 
phenyl-Sepharose facilitates the purification of C3d 
and obtaining specific immuneserum. Furthermore, 
it will be possible to obtain more complete informa- 
tions about the structure of this C3 fragment that 
probably plays an important part in the biological 
properties of C3. 
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